Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Gracell Biotechnologies Inc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gracell Biotechnologies Inc - ADR market cap is $991.3M.
What is the 52-week high for Gracell Biotechnologies Inc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gracell Biotechnologies Inc - ADR 52 week high is $10.44 as of October 10, 2025.
What is the 52-week low for Gracell Biotechnologies Inc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gracell Biotechnologies Inc - ADR 52 week low is $1.40 as of October 10, 2025.
What is Gracell Biotechnologies Inc - ADR stock price today?
Gracell Biotechnologies Inc - ADR stock price today is $10.25.
What was Gracell Biotechnologies Inc - ADR stock price yesterday?
Gracell Biotechnologies Inc - ADR stock price yesterday was $10.25.
What is the PE ratio of Gracell Biotechnologies Inc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gracell Biotechnologies Inc - ADR’s P/E ratio is -10.08.
What is the Price-to-Book ratio of Gracell Biotechnologies Inc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gracell Biotechnologies Inc - ADR P/B ratio is 4.4302.
What is the 50-day moving average of Gracell Biotechnologies Inc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gracell Biotechnologies Inc - ADR 50-day moving average is $9.82.